MiTeGen Announces Diode Beam Stop License Agreement with Lawrence Berkeley Laboratory
Ithaca, NY, December 17, 2015 --(PR.com)-- MiTeGen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed an exclusive licensing agreement with Lawrence Berkeley National Laboratory (Berkeley Lab) for the commercialization and distribution of Diode Beam Stops for real time measurement of X-ray Beam intensity, a technology developed by Diane Bryant and Simon Morton at the Berkeley Center for Structural Biology at Berkeley Lab.
X-ray science is a foundational tool used to determine the arrangement of atoms in minerals, metals and complex biological molecules such as proteins and DNA. Optimized X-ray beamlines are critical for the advancement of potentially lifesaving discoveries in material, medical and biological sciences.
"The work done by the team at Lawrence Berkeley National Lab has resulted in a great tool for monitoring X-ray diffraction experiments," says Robert Newman, CEO of MiTeGen. "The diode beam stop device will enable researchers to obtain real-time information about the intensity of the X-rays hitting their samples. We here at MiTeGen are very excited to bring this enabling technology to the marketplace and help push research forward."
Under the agreement, MiTeGen will develop and market products implementing the Berkeley Lab-developed diode beam stop (DBS) technology, and will have exclusive license to the technology. MiTeGen will focus on developing and commercializing an improved beamstop for both synchrotron beam lines and home sources. MiTeGen’s product is scheduled to be available by the Denver ACA meeting in July 2016.
“MiTeGen’s implementation plans demonstrate the importance of industry partnerships to achieving Berkeley Lab’s mission of delivering science solutions to the world,” says Elsie Quaite-Randall, the lab’s Chief Technology Transfer Officer. “Technology licensing, as in the case of MiTeGen, along with collaborative research, industry consortia, and other partnership models, are crucial to launching innovative discoveries into the marketplace where they can benefit society.”
About Berkeley Lab
Lawrence Berkeley National Laboratory (Berkeley Lab), www.lbl.gov, delivers science solutions to the world – solutions derived from the hundreds of patented and patent pending inventions plus copyrighted software in the Lab’s portfolio as well as scores of peer-reviewed manuscripts published each year in premier scientific publications. The University of California manages Berkeley Lab for the U.S. Department of Energy’s Office of Science, the single largest supporter of basic research in the physical sciences in the United States. Berkeley Lab’s Innovation and Partnerships Office, ipo.lbl.gov, connects industry partners with lab innovations, enabling lab-to-market transition.
About MiTeGen
Because our customers’ research is important, we provide innovative tools and solutions that measurably improve the ease, reproducibility, and quality of their experiments. MiTeGen engineers, manufactures and distributes a full range of the best products for the expression, crystallization, crystal harvesting, and X-ray diffraction data collection of proteins, viruses and small molecule/inorganic compounds. Our customers include academic, medical, pharmaceutical, government and industrial laboratories in more than 45 countries. Founded in 2004, MiTeGen is based in Ithaca, NY.
More information can be found at www.MiTeGen.com
X-ray science is a foundational tool used to determine the arrangement of atoms in minerals, metals and complex biological molecules such as proteins and DNA. Optimized X-ray beamlines are critical for the advancement of potentially lifesaving discoveries in material, medical and biological sciences.
"The work done by the team at Lawrence Berkeley National Lab has resulted in a great tool for monitoring X-ray diffraction experiments," says Robert Newman, CEO of MiTeGen. "The diode beam stop device will enable researchers to obtain real-time information about the intensity of the X-rays hitting their samples. We here at MiTeGen are very excited to bring this enabling technology to the marketplace and help push research forward."
Under the agreement, MiTeGen will develop and market products implementing the Berkeley Lab-developed diode beam stop (DBS) technology, and will have exclusive license to the technology. MiTeGen will focus on developing and commercializing an improved beamstop for both synchrotron beam lines and home sources. MiTeGen’s product is scheduled to be available by the Denver ACA meeting in July 2016.
“MiTeGen’s implementation plans demonstrate the importance of industry partnerships to achieving Berkeley Lab’s mission of delivering science solutions to the world,” says Elsie Quaite-Randall, the lab’s Chief Technology Transfer Officer. “Technology licensing, as in the case of MiTeGen, along with collaborative research, industry consortia, and other partnership models, are crucial to launching innovative discoveries into the marketplace where they can benefit society.”
About Berkeley Lab
Lawrence Berkeley National Laboratory (Berkeley Lab), www.lbl.gov, delivers science solutions to the world – solutions derived from the hundreds of patented and patent pending inventions plus copyrighted software in the Lab’s portfolio as well as scores of peer-reviewed manuscripts published each year in premier scientific publications. The University of California manages Berkeley Lab for the U.S. Department of Energy’s Office of Science, the single largest supporter of basic research in the physical sciences in the United States. Berkeley Lab’s Innovation and Partnerships Office, ipo.lbl.gov, connects industry partners with lab innovations, enabling lab-to-market transition.
About MiTeGen
Because our customers’ research is important, we provide innovative tools and solutions that measurably improve the ease, reproducibility, and quality of their experiments. MiTeGen engineers, manufactures and distributes a full range of the best products for the expression, crystallization, crystal harvesting, and X-ray diffraction data collection of proteins, viruses and small molecule/inorganic compounds. Our customers include academic, medical, pharmaceutical, government and industrial laboratories in more than 45 countries. Founded in 2004, MiTeGen is based in Ithaca, NY.
More information can be found at www.MiTeGen.com
Contact
Mitegen, LLC
Robert Newman
607-266-8877
www.mitegen.com
Robert Newman
607-266-8877
www.mitegen.com
Contact
Categories